In a research report sent to investors today, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Gilead Sciences (NASDAQ:GILD) with a …
Piper Jaffray’s healthcare analyst Joshua Schimmer is weighing in on Gilead Sciences’ (NASDAQ:GILD), after the company reported a solid fourth-quarter performance led by the HCV franchise, but conservatively guided below …
In a research report published Wednesday, Piper Jaffray analyst Joshua Schimmer downgraded shares of Isis Pharmaceuticals (NASDAQ:ISIS) to Neutral, and reduced the price target to …
Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in with an update on Celgene Corporation (NASDAQ:CELG), as the company reported yesterday morning full fourth-quarter results and guidance. The analyst …
In a research note issued today, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Biogen (NASDAQ:BIIB) with a $386 price target, following last …
Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in today with his thoughts on Biogen Idec (NASDAQ:BIIB), following the results from a phase 2 study of …
In a research report published today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $147, …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer weighed in with his thoughts on Gilead Sciences (NASDAQ:GILD), following the news that Express Scripts (NASDAQ:ESRX) has …
Ebay Inc. (NASDAQ: EBAY) is a San Jose, California based multinational Internet consumer-to-consumer corporation, comprising of more than 128 million active users around the …
In a research report released today, Piper Jaffray analyst Charles Duncan reiterated a Overweight rating on Inovio Pharmaceuticals (NASDAQ:INO) with a $29 price target, as the company recently …
